galactose has been researched along with squamosamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, F; Liu, G | 1 |
| Fang, F; Liu, GT; Wang, QL | 1 |
2 other study(ies) available for galactose and squamosamide
| Article | Year |
|---|---|
A novel cyclic squamosamide analogue compound FLZ improves memory impairment in artificial senescence mice induced by chronic injection of D-galactose and NaNO2.
Topics: Administration, Oral; Aging; Animals; Annona; Benzeneacetamides; Blotting, Western; Dementia; Dose-Response Relationship, Drug; Galactose; Gene Expression Regulation; Glutathione Peroxidase; Hippocampus; Male; Malondialdehyde; Maze Learning; Memory Disorders; Mice; Mice, Inbred ICR; Microscopy; Phenols; Proto-Oncogene Proteins c-bcl-2; Sodium Nitrite; Superoxide Dismutase; Time Factors | 2007 |
FLZ, synthetic squamosamide cyclic derivative, attenuates memory deficit and pathological changes in mice with experimentally induced aging.
Topics: Aging; Animals; Avoidance Learning; Benzeneacetamides; Brain; Disease Models, Animal; Galactose; Glutathione Peroxidase; Male; Malondialdehyde; Memory Disorders; Mice; Mice, Inbred ICR; Monoamine Oxidase; Neurons; Neuroprotective Agents; Phenols; Sodium Nitrite | 2012 |